Status:

COMPLETED

Effect of Antenatal Corticosteroids on Neonatal Morbidity.

Lead Sponsor:

Ahmadu Bello University Teaching Hospital

Conditions:

Neonatal Respiratory Distress Syndrome

Eligibility:

FEMALE

18-49 years

Phase:

NA

Brief Summary

It will be a randomized controlled trial. There will be two study groups. Study group 1 will be given dexamethasone while study group 2 will be given betamethasone. The control group will be given pla...

Detailed Description

The study will be a double blind randomised controlled trial. There will be two study groups and one control group. The first study group will be the pregnant women at risk of late preterm birth that...

Eligibility Criteria

Inclusion

  • Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation and a probability of delivery in the late preterm period irrespective of diagnosis who give consent.
  • Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation scheduled for elective/emergency delivery in the late preterm period irrespective of indication and route of delivery who give consent.

Exclusion

  • Evidence of Chrioamnionitis.
  • Evidence of foetal distress.
  • History of use of antenatal corticosteroids in index pregnancy.
  • Women who do not give consent.

Key Trial Info

Start Date :

December 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 31 2019

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT03446937

Start Date

December 1 2017

End Date

May 31 2019

Last Update

December 27 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ahmadu Bello University Teaching Hospital Shika-Zaria

Zaria, Kaduna State, Nigeria, PMB 06